COLLABORATION WITH CANCER RESEARCH INITIATIVES

Our mission is about tackling cancer health inequalities that hit Black and Minority Ethnic groups the hardest, especially with conditions like breast and prostate cancer, and multiple myeloma. These conditions are way more common in people of Black African and Black Caribbean descent, with their risks being twice as high as for that of the white population. 

A huge part of the problem is that Black and minority ethnic groups are often left out of clinical trials. Hence, the medical research and treatments that come out of those trials often don't work as effectively as with the white population. This is because epigenetic, environmental, and lifestyle differences can affect how diseases show up and how treatments work.

We want to change this by providing information and opportunities to take part in clinical trials and medical research. It's not just about making sure these communities benefit from new medical breakthroughs; it's also about understanding how diseases affect different people. By doing this, the Foundation aims to make health care fairer and ensure that treatments work well for everyone, no matter their background. 


Current Initiatives

For more information or to take part, call us on 07492830786 or use the contact form below.


TRANSFORM

We are working with University College London to identify 10 Black men who have been diagnosed with prostate cancer in the last 10 years to hear about their experiences with treatment.  This will be an interview online or face-to-face with a qualified researcher.   

A recent study found that Black men with prostate cancer often have a hard time sticking to their treatment. There is a need to find out why and address this. Previous research has shown that some of the things that make it hard for Black men to stick to their treatment include not trusting the healthcare system and not having information that is culturally adequate or sensitive.   There is a £20 incentive for taking part.
End Date 30/05/2024  (CODE NO. TRANS-01)